Lachrymal determinations: Methods and updates on biopharmaceutical and clinical applications

Ophthalmic Research

Volumn 36, Issue 4, 2004, Pages 183-194

  Dumortier, G ^a   Chaumeil, J C ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Diagnosis; Kinetics; Lachrymal determination; Lachrymal film; Ophthalmic solution; Pharmaceutical evaluation

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; BIOCHEMICAL MARKER; CARBAMAZEPINE; CEPHALOSPORIN; CETIRIZINE; CYCLOSPORIN A; DOCETAXEL; ENOXACIN; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; IODINE 123; LEVOFLOXACIN; LOCAL ANESTHETIC AGENT; LOMEFLOXACIN; MACROLIDE; METHOTREXATE; MINOCYCLINE; OFLOXACIN; OXYBUPROCAINE; PARACETAMOL; PENTOBARBITAL; PHENOBARBITAL; PILOCARPINE; PROXYMETACAINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; UNINDEXED DRUG;

ANALYTIC METHOD; CONJUNCTIVITIS; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DILUTION; DISEASE MARKER; DRUG DETERMINATION; DRUG MONITORING; EPITHELIUM; EXPERIMENTATION; EYE DISEASE; EYE INFLAMMATION; HUMAN; INFECTION; INFLAMMATION; LACRIMAL FLUID; LACRIMATION; MEDICAL INSTRUMENTATION; NONHUMAN; PLASMA; PRIORITY JOURNAL; REVIEW; SAMPLING; SCHIRMER TEST; STIMULATION;

BIOLOGICAL MARKERS; BODY FLUIDS; EYE DISEASES; HUMANS; LACRIMAL APPARATUS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SPECIMEN HANDLING; TEARS;

EID: 4043065777     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078776     Document Type: Review

References (126)

1. Hurwitz JJ: The Lacrimal System. New York, Lippincott-Raven, 1996.
2. Pouliquen Y: Précis d'ophtalmologie. Paris, Masson, 1984.
3. Monaco F, Piredda S, Mutant R, Mastropaolo C, Tondi M: Tears as the best practical indicator of the unbound fraction of an anticonvulsant drug. Epilepsia 1979;20:705-710.
4. Chrai SS, Patton TF, Mehta A, Robinson JR: Lachrymal and instilled fluid dynamics in rabbits eyes. J Pharm Sci 1973;62:1112-1121.
5. Domingo I, Coll J, Ribas-Montobio J, Marrugat J, Rubies-Prat J: Lacrimal immunoglobulins in rheumatoid arthritis patients with or without Sjögren's syndrome. Ophthalmologica 1998;212:30-33.
6. Gogia R, Richer SP, Rose RC: Tear fluid content of electrochemically active components including water-soluble antioxidants. Curr Eye Res 1998;17:257-263.
7. Green LC, Callegan MC, Engel LS, Shimomura Y, Jasheway DW, O'Callaghan RJ, Hill JM: Pharmacokinetics of topically applied ciprofloxacin in rabbit tears. Jpn J Ophthalmol 1996;40:123-126.
8. Sasaki H, Yamamura K, Mukai T, Nishida K, Nakamura J, Nakashima M, Ichikawa M: Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits. Biol Pharm Bull 1999;22:1253-1255.
9. Saettone MF, Giannaccini B, Barattini F, Tellini N: The validity of rabbits for investigation on ophthalmic vehicles: A comparison of four different vehicles containing tropicamide in humans and rabbits. Pharm Acta Helv 1982;57:47-55.
10. Marcozzi FG, Madia F, Del Bianco G, Mattei E, de Feo G: Lacrimal fluid peroxidase activity during the menstrual cycle. Curr Eye Res 2000;20:178-82.
11. Romano A, Peisich A, Madjarov B: The circadian rhythm of lachrymal secretion and its parameters, determined in a group of healthy individuals, and its potential diagnostic and therapeutic significance; in Sullivan SA (ed): Lachrymal Gland, Tear Film and Dry Eye Syndromes. New York, Plenum Press, 1994, pp 93-97.
12. Fullard RJ, Carney LG: Diurnal variations in human tear enzymes. Exp Eye Res 1984;38:15-16.
13. Ehlers N, Kessing SV, Norn MS: Quantitative amounts of conjunctival mucous secretions and tears. Acta Ophthalmol (Copenh) 1972;50:210-214.
14. Ng V, Cho P, Mak S, Lee A: Variability of tear protein levels in normal young adults: Between-day variation. Graefes Arch Clin Exp Ophthalmol 2000;238:892-899.
15. Ng V, Cho P, Wong F, Chan Y: Variability of tear protein levels in normal young adults: Diurnal (daytime) variation. Graefes Arch Clin Exp Ophthalmol 2001;239:257-263.
16. Sitaramamma T, Shivaji S, Rao GN: HPLC analysis of closed, open, and reflex eye tear proteins. Indian J Ophthalmol 1998;46:239-245.
17. Evans V, Vockler C, Friedlander M, Walsh B, Willcox MD: Lacryglobin in human tears, a potential marker for cancer. Clin Experiment Ophthalmol 2001;29:161-163.
18. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP: Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: Allergics vs non-allergics. J Immunol Methods 2001;254:109-118.
19. Sitaramamma T, Shivaji S, Rao GN: Effect of storage on protein concentration of tear samples. Curr Eye Res 1998;17:1027-1035.
20. Amdidouche D, Liotet S, Dutertre H, Chaumeil JC: In vivo assessment of new ophthalmic preparations in rabbit eye. STP Pharm Sci 1992;2:49-52.
21. Grabner G, Formanek I, Dorda W, Luger T: Human tear lysosyme: A comparison of electro-immunodiffusion and a spectrophotometric assay. Graefes Arch Clin Exp Ophthalmol 1982;218:265-270.
22. Lamberts DW, Foster CS, Perry HD: Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol 1979;97:1082-1085.
23. Varnell RJ, Freeman JY, Maitchouk D, Beuerman RW, Gebhardt BM: Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. Curr Eye Res 1997;16:960-963.
24. Frey WH, Desota-Johnson D, Hoffman C: Effect of stimulus on the chemical composition of human tears. Am J Ophthalmol 1981;92:559-567.
25. Tuft SJ, Dart JKG: The measurement of IgE in tear fluid: A comparison of collection by sponge and capillary. Acta Ophthalmol (Copenh) 1989;67:301-305.
26. Yamada M, Ogata M, Kawai M, Mashima Y, Nishida T: Substance P and its metabolites in normal human tears. Invest Ophthalmol Vis Sci 2002;43:2622-2655.
27. Scuderi AC, De LA, Miano F, Zola P: Residence time of netilmicin in tears. Cornea 2002;21:48-50.
28. Nakamura Y, Yokoi N, Tokushige H, Kinoshita S: Sialic acid in normal human tears. Nippon Ganka Gakkai Zasshi 2000;104:621-625.
29. Saso L, Tommasino P, Grippa E, Leone MG, Silvestrini B: Micromethods for the analysis of tear proteins in pharmacological studies. Res Commun Mol Pathol Pharmacol 1999;103:149-165.
30. Pandit JC, Nagyova B, Bron AJ, Tiffany JM: Physical properties of stimulated and unstimulated tears. Exp Eye Res 1999;68:247-253.
31. Struck HG, Wicht A, Ponicke K, Lautenschlager C, Lubbe D: Histamine in tears in allergic rhinoconjunctivitis. Ophthalmologe 1998;95:241-246.
32. Rahe BS, van Haeringen NJ: Cystatins in tears of patients with different corneal conditions. Ophthalmologica 1998;212:34-36.
33. Jones DT, Monroy D, Pflugfelder SC: A novel method of tear collection: Comparison of glass capillary micropipettes with porous polyester rods. Cornea 1997;16:450-458.
34. Monaco F, Piredda S, Mutant R, Mastropaolo C, Tondi M: The free fraction of valproic acid in tears, saliva and cerebrospinal fluid. Epilepsia 1982;23:23-26.
35. Berta A: Standardization of tear protein determinations. The effects of sampling, flow rate and vascular permeability; in Holly FJ (ed): The Preocular Tear Film in Health, Disease and Contact Lens Wear. Lubbock, Dry Eye Institute, 1986, p 433.
36. Grus FH, Augustin AJ: High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. Eur J Ophthalmol 2001;11:19-24.
37. Van Haeringen NJ: Clinical biochemistry of tears. Surv Ophthalmol 1981;26:84-92.
38. Bloomfield SE, Miyata T, Dunn WM, Buser N: Soluble gentamicin ophthalmic inserts as a drug delivery system. Arch Ophthalmol 1978;96:885-887.
39. Kuizenga AB, Van Agtmaal EJ, Van Haeringen NJ, Kislstra A: Sialic acid in human tear fluid. Exp Eye Res 1989;50:45-50.
40. Small D, Hevy J, Tang-Liu D: Comparison of tear sampling techniques for pharmacokinetics analysis: Ofloxacin concentrations in rabbit tears after sampling with Schirmer tear strips, capillary tubes, or surgical sponges. J Ocul Pharmacol Ther 2000;16:439-446.
41. Lifshitz M, Weinstein O, Gavrilov V, Rosenthal G, Lifshitz T: Acetaminophen (paracetamol) levels in human tears. Ther Drug Monit 1999;21:544-546
42. Fukuda M, Fullard RJ, Willcox MD, Baleriola-Lucas C, Bestawros F, Sweeney D, Holden BA: Fibronectin in the tear film. Invest Ophthalmol Vis Sci 1996;37:459-467.
43. Choy CK, Cho P, Chung WY, Benzie IF: Water-soluble antioxidants in human tears: Effect of the collection method. Invest Ophthalmol Vis Sci 2001;42:3130-3134.
44. Fullard RJ, Tucker D: Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci 1991;32:2290-2301.
45. Fullard RJ, Tucker D: Tear protein composition and the effect of stimulus; in Sullivan SA (ed): Lachrymal Gland, Tear Film and Dry Eye Syndromes. New York, Plenum Press, 1994, pp 309-314.
46. Virtanen T, Konttinen YT, Honkanen N, Harkonen M, Tervo T: Tear fluid plasmin activity of dry eye patients with Sjögren's syndrome. Acta Ophthalmol Scand 1997;75:137-141.
47. Oya T, Obata H, Miyata K, Tsuru T, Miyauchi S: Quantitative analyses of glycosaminoglycans in tear fluids in normal human eyes and eyes with corneal epithelial disorders. Nippon Ganka Gakkai Zasshi 1995;99:302-307.
48. Hyphe RTJ: Fluid uptake in schirmer papers and its relevance to their employment in tear collection for lysosyme tests. Br J Ophthalmol 1980;64:696-699.
49. Streiff H: Exploration du film lacrymal: revue de la littérature et essais personnels. Thèse d'exercice de docteur en médecine, Nancy-I, 1987.
50. Raizman MB, Rubin JM, Graves AL, Rinehart M: Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers. Clin Ther 2002;24:1439-1450.
51. Bakheet SM, Hammami MM, Hemidan A, Powe JE, Bajaafar F: Radioiodine secretion in tears. J Nucl Med 1998;39:1452-1454.
52. Nomura K, Takamura E: Tear IgE concentrations in allergic conjunctivitis. Eye 1998;12:296-298.
53. Limberg M, Bugge C: Tear concentrations of topically applied ciprofloxacin. Cornea 1994;13:496-499.
54. Klaeger AJ, Whitcher JP, Daniels TE: Tear lysozyme activity in frozen Schirmer strips and salivary gland biopsy as parameters of lacrimal gland function. Ocul Immunol Inflamm 1999;7:3-6.
55. Shani L, Santon E, David R, Yassur Y, Sarov I: Studies on HSV specific IgA antibodies in lachrymal fluid from patients with herpes keratitis by solid phase radioimmunoassay. Curr Eye Res 1985;4:103-112.
56. Stuchell RN, Farris LR, Mandel ID: Methods of studying proteins in the tear fluid; in Holly FJ (ed): The Preocular Tear Film in Health, Disease and Contact Lens Wear. Lubbock, Dry Eye Institute, 1986, pp 462-470.
57. Kang J, Fulop G, Friedman AH: Tear urea, nitrogen and creatinine levels in renal patients. Acta Ophthalmol 1988;66:407-412.
58. Dumortier G, Zuber M, Barges N, Chast F, Dutertre H, Chaumeil JC: Lachrymal and plasmatic kinetics of morphine after an ophthalmic delivery of three different formulations. Drug Dev Ind Pharm 1994;20:1147-1158.
59. Milder B, Weil BA: The Lachrymal System. Appleton, Century Crofts, 1983.
60. Norn M: Sampling methods for tear stix tests. Acta Ophthalmol 1992;70:754-757.
61. Berta A: Collection of tear samples with or without stimulation. Am J Ophthalmol 1983;96:115-116.
62. Stuchell RN, Feldman JJ, Farris RL, Mandel ID: The effect of collection technique on tear composition. Invest Ophthalmol Vis Sci 1984;25:374-377.
63. Terekhina NA, Petrovich IuA: Diagnostic value of tear analysis in uremia, uricemia and cholesterolemia. Klin Lab Diagn 1994;6:17-18.
64. Ding S, Chen CC, Salome-Kesslak R, Tang-Liu DDS, Himmstein KJ: Precorneal sampling techniques for ophthalmic gels. J Ocul Pharmacol 1992;8:151-159.
65. Raines DA, Yusuf A, Jabak MH, Ahmed WS, Karcioglu ZA, El-Yazigi A: Simultaneous highperformance liquid chromatography analysis of azithromycin and two of its metabolites in human tears and plasma. Ther Drug Monit 1998;20:680-684.
66. Liotet S: Local synthesis of lacrimal specific IgE in allergic conjunctivitis; in Holly FJ (ed): The Preocular Tear Film in Health, Disease and Contact Lens Wear. Lubbock, Dry Eye Institute, 1986, pp 788-790.
67. Leonardi A, Battista MC, Gismondi M, Fregona IA, Secchi AG: Antigen sensitivity evaluated by tear specific and serum specific IgE, skin tests and conjunctival and nasal provocation tests in patients with ocular allergic disease. Eye 1993;73:461-464.
68. Baleriola-Lucas C, Fukuda M, Willcox MD, Sweeney DF, Holden BA: Fibronectin concentration in tears of contact lens wearers. Exp Eye Res 1997;64:37-43.
69. Kiratli H, Irkec M, Orhan M: Tear lactoferrin levels in chronic meibomitis associated with acne rosacea. Eur J Ophthalmol 2000;10:11-14.
70. Fujishima H, Takeyama M, Takeuchi T, Saito I, Tsubota K: Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy 1997;27:372-378.
71. Mieyal PA, Dunn MW, Schwartzman ML: Detection of endogenous 12-hydroxyeicosatrienoic acid in human tear film. Invest Ophthalmol Vis Sci 2001;42:328-332.
72. Yamamoto S, Shimomura Y, Kinoshita S, Nishida K, Yamamoto R, Tano Y: Detection of herpes virus DNA in human tear film by the polymerase chain reaction. Am J Ophthalmol 1994;117:160-163.
73. Abiko Y, Ikeda M, Hondo R: Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell's palsy. Otol Neurotol 2002;23:779-783.
74. Hiroshige K, Ikeda M, Hondo R: Detection of varicella-zoster virus DNA in tear fluid and saliva of patients with Ramsay Hunt syndrome. Nippon Jibiinkoka Gakkai Kaiho 2000;103:928-936.
75. Strubbe DT, Brooks DE, Schultz GS, Willis-Goulet H, Gelatt KN, Andrew SE, Kallberg ME, MacKay EO, Collante WR: Evaluation of tear film proteinases in horses with ulcerative keratitis. Vet Ophthalmol 2000;3:111-119.
76. Tabbara KF: Tear tryptase in vernal keratoconjunctivitis. Arch Ophthalmol 2001;119:338-342.
77. Brown SI: Collagenase and corneal ulcers. Invest Ophthalmol 1971;10:203-209.
78. Berman MB, Barder JC, Talamo RC, Langley CE: Corneal ulceration and the serum antiprotease. 1. Alphal antitrypsin. Invest Ophthalmol 1973;12:759-770.
79. Garcher C, Bron A, Baudouin C, Bildstein L, Bara J: CA 19-9 ELISA test: A new method for studying mucus changes in tears. Br J Ophthalmol 1998;82:88-90.
80. Karakucuk S, Mirza GE, Karakucuk I, Akal A, Er M: Nitric oxide levels in tears of patients with mild forms of papillary conjunctivitis induced by rigid gas-permeable contact lenses. CLAO J 2002;28:5-8.
81. Yamada M, Ogata M, Kawai M, Mashima Y: Decreased substance P concentrations in tears from patients with corneal hypesthesia. Am J Ophthalmol 2000;129:671-672.
82. Avisar R, Menache R, Shaked P: Lysosyme content of tears in patients with Sjögren's syndrome and rheumatoid arthritis. Am J Ophthalmol 1979;87:151-160.
83. Carmody PJ, Rattazi MC, Davidson RG: Tay-Sachs disease: The use of tears for the detection of heterozygotes. Am J Hum Gen 1972;24:30a.
84. Tsuboyama A, Miki F, Yoshida M, Ogura Y, Miyatake T: The use of tears for diagnosis of GMI gangliosidosis. Clin Chem Acta 1977;80:237-242.
85. Sharma OP, Vita JB: Determination of angiotensin converting enzyme activity in tears: A non-invasive test for evaluation of ocular sarcoidosis. Arch Ophthalmol 1983;101:559-561.
86. Whiting PH, Ross IS, Borthwick LJ: N-Acetylβ-D-glucosaminidase levels and diabetic microangiopathy. Clin Chem Acta 1979;97:191-195.
87. Zubareva TV, Kiseleva ZM: Cathecholamine content of the lachrymal fluid of healthy people and glaucoma patients. Ophthalmologica (Basel) 1977;175:339-344.
88. Macri A, Rolando M, Pflugfelder S: A standardized visual scale for evaluation of tear fluorescein clearance. Ophthalmology 2000;107:1338-1343.
89. Gasset AR, Braverman LE, Flemming MC: Tear glucose detection of hyperglycemia. Am J Ophthalmol 1968;65:414.
90. Van Haeringen NJ, Glasius E: Collection method dependent concentrations of some metabolites in human tear fluid, with special reference to glucose in hyperglycaemic conditions. Graefes Arch Klin Ophthalmol 1977;202:1-7.
91. Meek B, Klaren VN, Van Haeringen NJ, Kijlstra A, Peek R: IgA antibodies to Toxoplasma gondii in human tears. Invest Ophthalmol Vis Sci 2000;41:2584-2590.
92. Chan J, Cheek SL, Slagle T, Green K: Relationship between plasma and tear fluoride levels in rabbit and man. Ophthalmic Res 1990;22:39-44.
93. Carney LG, Hill RM: Human tear pH, diurnal variations. Arch Ophthalmol 1976;94:821-824.
94. Hamano H: Viscosity of tears. Acta Soc Ophthalmol Jp 1973;77:704-711.
95. Baeyens V, Gurny R: Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. Pharm Acta Helv 1997;72:191-202.
96. Janszky I, Vamosi P, Orszagh I, Berta A: Demonstration of increasing standard pH value of lacrimal fluid with increase of flow rate. J Cataract Refract Surg 2001;27:585-588.
97. Tondi M, Mutant R, Mastropaolo C, Monaco F: Greater reliability of tear versus saliva anticonvulsivant levels. Ann Neurol 1978;4:401-405.
98. Stoehr GP, Venkaramanan R, Dauber JH: Comparison of methods for determining unbound theophylline concentrations. Ther Drug Monit 1986;8:42-46.
99. Steele WH, Stuart JFB, Whithing B: Serum, tear and salivary concentrations of methotrexate in man. Br J Clin Pharmacol 1987;7:207-212.
100. Giles HG, Sandrin S, Saldivia V, Israel Y: Non-invasive estimation of blood alcohol concentrations: Ethanol vapor above the eye. Alcohol Clin Exp Res 1988;12:255-258.
101. Esmaeli B, Ahmadi MA, Rivera E, Valero V, Hutto T, Jackson DM, Newman RA: Docetaxel secretion in tears: Association with lacrimal drainage obstruction. Arch Ophthalmol 2002;120:1180-1182.
102. Benezra D, Maftzir G, De Courten C, Timonen P: Ocular penetration of ciclosporin A. 3. The human eye. Br J Ophthalmol 1990;74:350-352.
103. Diaz-Llopis M, Menezo JL: Penetration of 2% ciclosporin eyedrops into human aqueous humour. Br J Ophthalmol 1989;73:600-603.
104. Grumetto L, Cennamo G, Del Prete A, La Rotonda MI, Barbato F: Pharmacokinetics of cetirizine in tear fluid after a single oral dose. Clin Pharmacokinet 2002;41:525-531.
105. Del Castillo JM: Componentes endogenos yatrogenicos; Del Castillo JM (ed): Dacryologia Basica. Madrid, Induphoto, 1982, pp 572-573.
106. Fraunfelder FM: Orange tears. Am J Ophthalmol 1980;5:752.
107. Barza M, Kane A, Baum J: Excretion of gentamicin in rabbit tears after subconjunctival injection. Am J Ophthalmol 1978;85:118-120.
108. Tokuda H, Hatano H: Studies of the penetration of antibiotics into the tear. Acta Soc Ophthalmol Jp 1973;77:1168-1174.
109. Tabbara KF, Cooper H: Minocycline levels in tears of patients with active trachoma. Arch Ophthalmol 1989;107:93-95.
110. Tabbara KF, al-Kharashi SA, al-Mansouri SM, al-Omar OM, Cooper H, el-Asrar AM, Foulds G: Ocular levels of azithromycin. Arch Ophthalmol 1998;116:1625-1628
111. Tomii T, Murano H: Evaluation of a new method of sampling human tears. Atarashii Ganka 1993;10:243-246.
112. Jaehde U, Sorgel F, Naber KG, Zurcher J, Schunack W: Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers. Antimicrob Agents Chemother 1995;39:2092-2097.
113. Elena PP, Jauch A: Ocular distribution of lomefloxacin 0.3% after a single instillation in the infected eye of pigmented rabbits. J Ocul Pharmacol Ther 1997;13:551-558.
114. Akkan AG, Mutlu I, Ozyazgan S, Gok A, Yigit U, Ozuner Z, Senses V, Pekel H: Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes. Int J Clin Pharmacol Ther 1997;35:214-217.
115. Adler CA, Maurice DM, Paterson ME: The effect of viscosity of the vehicle on the penetration of fluorescein into the human eye. Exp Eye Res 1971;11:34-42.
116. Lee VHL, Robinson JR: Mechanistic and quantitative evaluation of precorneal pilocarpine in albinos rabbit. J Pharm Sci 1979;68:673-684.
117. Massey JY, Hanna C, Goodart R, Wallace T: Effect of drug vehicle on human ocular retention of topically applied tetracycline. Am J Ophthalmol 1976;81:151-156.
118. Van Bijsterveld OP, Andriesse H, Nielsen BH: Fusidic acid in tear fluid: Pharmacokinetic study with fusidic acid viscous eye drops. Eur J Drug Metab Pharmacokin 1987;2:215-218.
119. Keister JC, Cooper ER, Missel PJ, Lang JC, Hager DF: Limits on optimizing ocular drug delivery. J Pharm Sci 1991;80:50-53.
120. Hardberger R, Calvin H, Boyd CM: Effects of drug vehicles on ocular contact time. Arch Ophthalmol 1975;93:42-45.
121. Thorn P, Johansen S: Pharmacokinetic investigation of fusidic acid 1% viscous eye drops in healthy volunteers. Eur J Ophthalmol 1997;7:9-12.
122. Mishima S: Clinical pharmacokinetics of the eye. Invest Ophthalmol Vis Sci 1981;21:504-539.
123. Meadows DL, Paugh JR, Joshi A, Mordaunt J: A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. Invest Ophthalmol Vis Sci 2002 ;43:1032-1039.
124. Shrewsbury RP, Swarbrick J, Newton KS, Riggs LC: Influence of ophthalmic formulations on sodium cromoglycate disposition in the albinos rabbit eye. J Pharm Pharmacol 1985;37:614-617.
125. Urtti A, Juslin M, Miinalainen O: Pilocarpine release from hydroxypropyl cellulose-polyvinylpyrrolidone matrices. Int J Pharm 1985;25:165-178.
126. Kaltsatos V, Boisrame B, Deleforge J, Gex-Fabry M, Balant LP, Gurny R: Bioadhesive ophthalmic drug insert. Pharm Res 1995;12:1791-1795.